Literature DB >> 3257903

Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens.

L Romani1, U Grohmann, F Fazioli, P Puccetti, M G Mage, M C Fioretti.   

Abstract

T cell-mediated proliferative and cytotoxic responses occur in vitro to syngeneic tumor cells antigenically altered by mutagen treatment. One such xenogenized variant of the murine L5178Y lymphoma elicits IgG antibodies reactive with determinants on variant cells that are not expressed at detectable levels on parental or normal cells of the same H-2d haplotype and are also unrelated to public specificities of H-2b or H-2k histocompatibility antigens. In the present study we investigated the effect of those antibodies on development of cell-mediated responses in vitro to the xenogenized cells used for induction of the humoral response. The proliferative reaction, generation of cytolytic activity and target cell lysis were all inhibited by the anti-xenogenized tumor immune serum, whereas the corresponding reactions to the parental cells by syngeneic or allogeneic effector lymphocytes were not. In order to investigate the possible H-2 association of T cell-mediated responses to xenogenized cells, we also examined the effect on those reactions of antibodies specific for Class I or Class II products of the H-2d complex. The results obtained suggested a role for I-Ad molecules in the T cell proliferative response to the xenogenized cells, and also indicated a preferential association of the cytotoxic response with H-2Kd determinants.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257903     DOI: 10.1007/bf00199847

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  36 in total

1.  Inhibition of the induction of cytolytic T lymphocytes with alloantisera directed against H-2K and H-2D gene products.

Authors:  F Lemonnier; S J Burakoff; M Mescher; M E Dorf; B Benacerraf
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.

Authors:  E Bonmassar; A Bonmassar; S Vadlamudi; A Goldin
Journal:  Cancer Res       Date:  1972-07       Impact factor: 12.701

3.  Inhibition of antigen-induced T-cell clone proliferation by antigen-specific antibodies.

Authors:  G Corradin; H D Engers
Journal:  Nature       Date:  1984 Apr 5-11       Impact factor: 49.962

4.  In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo.

Authors:  L Romani; M C Fioretti; E Bonmassar
Journal:  Transplantation       Date:  1979-09       Impact factor: 4.939

5.  Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens.

Authors:  S L Swain; D P Dialynas; F W Fitch; M English
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

Review 6.  Chemical xenogenization of experimental tumors.

Authors:  P Puccetti; L Romani; M C Fioretti
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Nature of the antigenic complex recognized by T lymphocytes. VIII. Specific inhibition of the stimulatory capacity of antigen-pulsed hapten-modified peritoneal exudate cells by anti-hapten antibody.

Authors:  E M Shevach; C Chan; L T Clement
Journal:  Eur J Immunol       Date:  1982-10       Impact factor: 5.532

8.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

9.  Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant.

Authors:  L Romani; U Grohmann; P Puccetti; B Nardelli; M G Mage; M C Fioretti
Journal:  Cell Immunol       Date:  1988-02       Impact factor: 4.868

10.  Immunologically relevant peptide antigen exists on the presenting cell in a manner accessible to macromolecules in solution.

Authors:  K B Cease; G Buckenmeyer; I Berkower; J York-Jolley; J A Berzofsky
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.